Alembic Pharmaceuticals on Tuesday said its joint venture, Aleor Dermaceuticals has received approval from the US health regulator for its generic version of Temovate topical solution which is used to treat a variety of skin conditions.
Fougera Pharms's Generic Tazarotene Receives Approval in US
Enforcement Report - Week of March 29, 2017
Slayback Pharma LLC is pleased to announce the launch of Generic Zovirax Ointment (Acyclovir Ointment) 5%, by its out-licensee - Sandoz (Fougera). Slayback had developed the product and out-licensed the sales and marketing rights to Sandoz. The ANDA filed by Sandoz (Fougera) was approved on May 11, 2016.
Fougera Pharms Inc`s Generic Acyclovir approved in US as an antiviral medication
Sandoz will consolidate two New York sites manufacturing semi-solid creams and ointments for its dermatology subsidiary, Fougera Pharmaceuticals.